Novo Nordisk A/S Company Information
Novo Nordisk A/S's employee growth, exchange listings and data sources
Key Information
- Name: Novo Nordisk A/S
- Ticker: 0TDD
- Exchange: LSE
- Founded: 1923
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: DKK 3.414t
- Listing Market Cap: DKK 474.236b
- Shares Outstanding: 4.42b
- Website: https://www.novonordisk.com
Number of Employees
Location
- Novo Nordisk A/S
- Novo Alle 1
- Bagsvaerd
- Capital Region of Denmark
- 2880
- Denmark
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| NVO | NYSE (New York Stock Exchange) | ADR-EACH CNV INTO 1 CLASS'B'DKK1 | US | USD | Apr 1981 | |
| NOVA | DB (Deutsche Boerse AG) | ADR-EACH CNV INTO 1 CLASS'B'DKK1 | DE | EUR | Apr 1981 | |
| NVO N | BMV (Bolsa Mexicana de Valores) | ADR-EACH CNV INTO 1 CLASS'B'DKK1 | MX | MXN | Apr 1981 | |
| 0TDD | LSE (London Stock Exchange) | ADR-EACH CNV INTO 1 CLASS'B'DKK1 | GB | USD | Apr 1981 | |
| NONO.F | OTCPK (Pink Sheets LLC) | Yes | Class B Common Shares | US | USD | Jan 1992 |
| NOVOB | BRSE (Berne Stock Exchange) | Yes | Class B Common Shares | CH | CHF | Jan 1992 |
| 0QIU | LSE (London Stock Exchange) | Yes | Class B Common Shares | GB | DKK | Jan 1992 |
| NOV | DB (Deutsche Boerse AG) | Yes | Class B Common Shares | DE | EUR | Jan 1992 |
| NOVO B | CPSE (OMX Nordic Exchange Copenhagen) | Yes | Class B Common Shares | DK | DKK | Jan 1992 |
| NOV | XTRA (XETRA Trading Platform) | Yes | Class B Common Shares | DE | EUR | Jan 1992 |
| NNO2 | WBAG (Wiener Boerse AG) | Yes | Class B Common Shares | AT | EUR | Jan 1992 |
| NOVOB N | BMV (Bolsa Mexicana de Valores) | Yes | Class B Common Shares | MX | MXN | Jan 1992 |
| NOV | BUL (Bulgaria Stock Exchange) | Yes | Class B Common Shares | BG | EUR | Jan 1992 |
| NOVD | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Class B Common Shares | GB | EUR | Jan 1992 |
| NOVOBC | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Class B Common Shares | GB | DKK | Jan 1992 |
| N1VO34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 8 REPR 1 ADR | BR | BRL | Sep 2022 | |
| NOVOB80 | SET (The Stock Exchange of Thailand) | DR (1000:1) NOVO NORDISK | TH | THB | Oct 2024 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 04:03 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 04:03 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Novo Nordisk A/S is covered by 71 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Kamla Singh | AlphaValue |
| Gerhard Schwarz | Baader Helvea Equity Research |